Effect of combined therapy of oral anti-tubercular agents on theophylline pharmacokinetics

International Journal of Tuberculosis and Lung Disease

Volumn 4, Issue 8, 2000, Pages 784-787

  Ahn, H C ^a   Yang, J H ^a   Lee, H B ^a   Rhee, Y K ^a   Lee, Y C ^a  

^a Chonbuk National University Medical School   (South Korea)

Author keywords

Anti tubercular agents; Theophylline pharmacokinetics

Indexed keywords

ETHAMBUTOL; ETHEOPHYL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; THEOPHYLLINE; TUBERCULOSTATIC AGENT;

ADULT; ARTICLE; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; DOSE RESPONSE; DRUG CLEARANCE; DRUG HALF LIFE; FEMALE; HUMAN; LUNG TUBERCULOSIS; MALE; PRIORITY JOURNAL; SUSTAINED RELEASE PREPARATION;

ANTITUBERCULAR AGENTS; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; MIDDLE AGED; THEOPHYLLINE; TUBERCULOSIS;

EID: 0033846059     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Therapeutic activities of theophylline in chronic obstructive pulmonary disease
2. Theophylline inhibits the late asthmatic response to nighttime antigen challenge in patients with mild atopic asthma
3. Therapeutic and toxic theophylline levels in asthma attacks - Is there a need for additional theophylline?
4. Characterization of theophylline metabolism by human liver microsomes. Inhibition and immunochemical study
5. The effect of rifampin on theophylline kinetics
6. Theophylline-isoniazid interaction
7. Abbott PKS system, a new version for applied pharmacokinetics including Bayesian estimation
8. Methylcholanthrene but not phenobarbital enhances caffeine and theophylline metabolism in cultured adult human hepatocytes
9. Application of theophylline metabolite assays to the exploration of liver microsome oxidative function in man
10. Rifampicin-isoniazid and delayed elimination of theophylline: A case report